Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-25T05:56:49.424Z Has data issue: false hasContentIssue false

5 - Treatment

Published online by Cambridge University Press:  05 May 2015

Louis R. Caplan
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Vertebrobasilar Ischemia and Hemorrhage
Clinical Findings, Diagnosis and Management of Posterior Circulation Disease
 , pp. 163 - 178
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Caplan, LR. Treatment. In Caplan’s Stroke, a clinical approach, 4th edition. Saunders-Elsevier, Philadelphia, 2009, pp. 146–217.Google Scholar
2.Caplan, LR, Sergay, S. Positional cerebral ischemia. J Neurol Neurosurg Psychiatry 1976;39:385–391.CrossRefGoogle Scholar
3.Toole, J. Effects of change of head, limb, and body position on cephalic circulation. N Engl J Med 1968; 279:307–311.CrossRefGoogle ScholarPubMed
4.Wojner-Alexander, AW, Garami, Z, Chernyshev, OY, Alexandrov, AV. Heads down: flat positioning improves blood flow velocity in acute ischemic stroke. Neurology 2005;64;1354–1357.CrossRefGoogle ScholarPubMed
5.Rordorf, G, Cramer, SC, Efird, JT, Schwamm, LH, Buonanno, F. Koroshetz, WJ. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke 1997;28:2133–2138.CrossRefGoogle ScholarPubMed
6.Hillis, AE, Ulatowski, JA, Barker, PB, Torbey, M, Ziai, W., Wityk, RJ. A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerbrovasc Dis 2003;16(3):236–246.CrossRefGoogle ScholarPubMed
7.Chalela, JA, Dunn, B, Todd, JW, Warach, S. Induced hypertension improves cerebral blood flow in acute ischemic stroke. Neurology 2005;64:1979.CrossRefGoogle ScholarPubMed
8.Hillis, AE, Kane, A, Tufflash, E, Ulatowski, JA, Barker, PB, Beauchamp, NJ, Wityk, RJ. Reperfusion of specific brain regions by raising blood pressure restores selective language functions in subacute stroke. Brain Lang 2001;79:495–510.CrossRefGoogle ScholarPubMed
9.Hammer, M, Jovin, T, Wahr, J, Heiss, WD. Partial occlusion of the descending aorta increases cerebral blood flow in a non-stroke porcine model. Cerebrovasc Dis 2009;28:406–410.CrossRefGoogle Scholar
10.Liebeskind, DS. Aortic occlusion for cerebral ischemia: from theory to practice. Curr Cardiol Rep 2008;10:31–36.CrossRefGoogle ScholarPubMed
11.Simeone, FA. Enhancement of cerebral flood flow by intermittent aortic occlusion. Eur Neurol 1972;8:142–144.CrossRefGoogle ScholarPubMed
12.Shuaib, A. Bornstein, N, Diener, H-C et al. for the SENTIS Investigators. Partial aortic occlusion for cerebral perfusion augmentation. Safety and Efficacy of Neuroflo in Acute Ischemic Stroke Trial. Stroke 2011;42:1680–1690.CrossRefGoogle ScholarPubMed
13.Collen, D. On the regulation and control of fibrinolysis: Edward Kowalski Memorial Lecture. Thromb Haemost 1980; 43:77–89.Google Scholar
14.Sloan, MA. Thrombolysis and stroke, past and future. Arch Neurol 1987; 44:748–768.CrossRefGoogle ScholarPubMed
15.del Zoppo, GJ, Hosomi, N. Mechanisms of thrombolysis. In Lyden, PD (ed.), Thrombolytic therapy for acute stroke. Humana Press, Totowa, NJ, 2005, pp. 3–27.CrossRefGoogle Scholar
16.del Zoppo, GJ. Thrombolytic therapy in cerebrovascular disease. Stroke 1988; 19:1174–1179.CrossRefGoogle ScholarPubMed
17.Pessin, MS, del Zoppo, GJ, Furlan, AJ. Thrombolytic treatment in acute stroke: review and update of selected topics. In Cerebrovascular diseases, 19th Princeton Conference, 1994. Butterworth-Heinemann, Boston,1995; pp. 409–418.Google Scholar
18.The National Institute of Neurological Disorders and Stroke rt-PA Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.CrossRefGoogle Scholar
19.Hacke, W, Kaste, M, Fieschi, C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274:1017–1025.CrossRefGoogle ScholarPubMed
20.Hacke, W, Kaste, M, Fieschi, C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS ll). Lancet 1998;352:1245–1251.CrossRefGoogle Scholar
21.Clark, WM, Wissman, S, Albers, GW et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. Alteplase Thrombolysis for Acute Non-interventional Therapy in Acute Stroke. JAMA 1999 282:2019–2026.CrossRefGoogle Scholar
22.ATLANTIS, ECASS, and NINDS rt-PA Study group Investigators. Association of outcome with early stroke treatment. Pooled analysis of the ATLANTIS, ECASS, and NINDS stroke trials. Lancet 2004;363: 768–774.CrossRefGoogle Scholar
23.Furlan, AJ, Higashida, RT, Wechsler, L et al. PROACT II. Intra-arterial pro-urokinase for acute ischemic stroke. A randomized controlled trial. JAMA 1999;282;2003–2011.CrossRefGoogle ScholarPubMed
24.Hacke, W, Zeumer, H, Ferbert, A, Bruckmann, H, del Zoppo, G. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988;19:1216–1222.CrossRefGoogle ScholarPubMed
25.Caplan, LR. Treatment. In Caplan’s Stroke, a clinical approach, 4th edition. Saunders-Elsevier, Philadelphia, 2009, pp. 156–168.Google Scholar
26.Grond, M, Rudolf, J, Schmulling, S, Stenzel, C, Neveling, M, Heiss, W-D. Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke. Arch Neurol 1998;55:466–469.CrossRefGoogle ScholarPubMed
27.Montavont, A, Nighoghossian, N, Derex, L et al. Intravenous r-tPA in vertebrobasilar acute infarcts. Neurology 2004;62:1854–1856.CrossRefGoogle ScholarPubMed
28.Sarikaya, H, Arnold, A, Engelter, S et al. Outcomes of intravenous thrombolysis in posterior versus anterior circulation stroke. Stroke 2011;42:2498–2502.CrossRefGoogle ScholarPubMed
29.Lindsberg, P, Soinne, L, Tatlisumak, T et al. Long-term outcome after intravenous thrombolysis of basilar artery occlusion. JAMA 2004;292:1862–1866.CrossRefGoogle ScholarPubMed
30.Bhatia, R, Hill, M, Shobha, N et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke. Stroke 2010;41:2254–2258.CrossRefGoogle ScholarPubMed
31.Pagola, J, Ribo, M, Alvarez-Sabin, J et al. Thrombolysis in anterior versus posterior circulation strokes: timing of recanalization, ischemic tolerance, and other differences. J Neuroimaging 2011;21:108–112.CrossRefGoogle ScholarPubMed
32.Sairanen, T, Strbian, D, Soinne, L et al. for the Helsinki Stroke Thrombolysis Registry (HSTR) Group. Intravenous thrombolysis of basilar artery occlusion. Predictors of recanalization and outcome. Stroke 2011;42:2175–2179.CrossRefGoogle ScholarPubMed
33.Mendonça, N, Rodriguez-Luna, D, Rubiera, M et al. Predictors of tissue-type plasminogen activator nonresponders according to location of vessel occlusion. Stroke 2012;43:417–421.CrossRefGoogle ScholarPubMed
34.Caplan, LR. Thrombolysis in vertebrobasilar occlusive disease In Lyden, PD (ed.), Thrombolytic therapy for acute stroke, 2nd edition. Humana Press, Totowa, NJ, 2005, pp. 203–209.CrossRefGoogle Scholar
35.Mobius, E, Berg-Dammer, E, Kuhne, D, Nahser, HC. Local thrombolytic therapy in acute basilar artery occlusion. Experience with 18 patients. In Hacke, W, del Zoppo, GJ, Hirschberg, M (eds.), Thrombolytic therapy in acute ischemic stroke. Springer, Heidelberg, 1991, pp. 213–215.CrossRefGoogle Scholar
36.Brandt, T, von Kummer, R, Muller-Kuppers, M, Hacke, W. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 1996:27:875–881.CrossRefGoogle ScholarPubMed
37.Wijdicks, EFM, Nichols, DA, Thielen, KR et al. Intra-arterial thrombolysis in acute basilar artery thromboembolism: the initial Mayo Clinic experience. Mayo Clin Proc 1997;72:1005–1013.CrossRefGoogle ScholarPubMed
38.Cross, DT, Moran, CJ, Akins, PT, Angtuaco, E, Diringer, MN. Relationship between clot location and outcome after basilar artery thrombosis. AJNR Am J Neuroradiol 1997;18:1221–1228.Google Scholar
39.Mitchell, PJ, Gerraty, RP, Donnan, GA et al. Thrombolysis in the vertebrobasilar circulation: the Australian Urokinase Stroke Trial. Cerebrovasc Dis 1997;7:94–99.CrossRefGoogle Scholar
40.Egan, R, Clark, W, Lutsep, H, Nesbit, G, Barnwell, S, Kellogg, J. Efficacy of intraarterial thrombolysis of basilar artery stroke. J Stroke Cerebrovasc Dis 1999;8:22–27.CrossRefGoogle ScholarPubMed
41.Eckert, B, Kucinski, T, Pfeiffer, G, Groden, C, Zeumer, H. Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor. Cerebrovasc Dis 2002;14:42–50.CrossRefGoogle ScholarPubMed
42.Jung, S, Mono, M-L, Fischer, U et al. Three-month and long term outcomes and their predictors in acute basilar artery occlusion treated with intra-arterial thrombolysis. Stroke 2011;42:1946–1951.CrossRefGoogle ScholarPubMed
43.Karameshev, A, Arnold, M, Schroth, G et al. Diffusion-weighted MRI helps predict outcome in basilar artery occlusion patients treated with intra-arterial thrombolysis. Cerebrovasc Dis 2011;32:393–400.CrossRefGoogle ScholarPubMed
44.Macleod, MR, Davis, SM, Mitchell, PJ et al. Results of a multicentre randomized controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis 2005;20:12–17.CrossRefGoogle ScholarPubMed
45.Becker, KJ, Monstein, LH, Ulatowski, Mirski M, Williams, M, Hanley, DF. Intraarterial thrombolysis in vertebrobasilar occlusion. Am J Neuroradiol 1996;17:255–262.Google ScholarPubMed
46.Meier, N, Fischer, U, Schroth, G et al. Outcome after thrombolysis for acute posterior cerebral artery occlusion. Cerebrovasc Dis 2011;32:79–88.CrossRefGoogle ScholarPubMed
47.Barlinn, K, Becker, U, Puetz, V et al. Combined treatment with intravenous abciximab and intraarterial tPA yields higher recanalization rate in patients with acute basilar artery occlusion. J Neuroimag 2012;22:167–171.CrossRefGoogle Scholar
48.Pfefferkorn, T, Holtmannspötter, M, Schmidt, C et al. Drip, ship, and retrieve. Comparative recanalization therapy in acute basilar artery occlusion. Stroke 2010;41:722–726.CrossRefGoogle ScholarPubMed
49.Nagel, S, Schellinger, PD, Hartmann, M et al. Therapy of acute basilar artery occlusion. Intraarterial thrombolysis alone vs bridging therapy. Stroke 2009;40:140–146.CrossRefGoogle ScholarPubMed
50.Nakayama, T, Tanaka, K, Kaneko, M, Yokoyama, T, Uemura, K. Thrombolysis and angioplasty for acute occlusion of intracranial vertebrobasilar arteries. J Neurosurg 1998;88:919–922.CrossRefGoogle ScholarPubMed
51.Lin, R, Aleu, A, Jamkowitz, B et al. Endovascular revascularization of chronic symptomatic vertebrobasilar occlusion. J Neuroimaging 2012;22:74–79.CrossRefGoogle ScholarPubMed
52.Saver, JL. Mechanical thrombectomy devices for treatment of stroke. Neurol Clin Pract 2012;1: 231–234.Google Scholar
53.Smith, WS, Sung, G, Saver, JL et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi Merci trial. Stroke 2008;39:1205–1212.CrossRefGoogle ScholarPubMed
54.Penumbra Pivotal Stroke Trial Investigators. The PENUMBRA pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large artery occlusive disease. Stroke 2009;40:2761–2768.CrossRefGoogle Scholar
55.Roth, C, Mielke, A, Siekmann, R, Ferbert, A. First experience with a new device for mechanical thrombectomy in acute basilar artery occlusion. Cerebrovasc Dis 2011;32:28–34.CrossRefGoogle ScholarPubMed
56.Henkes, H, Flesser, A, Brew, S et al. A novel microcatheter-delivered highly-flexible and fully-retrievable stent specifically designed for intracranial use. Interv Neuroradiol 2003;9:391–393.Google Scholar
57.Jankowitz, B, Aleu, A, Lin, R et al. Endovascular treatment of basilar artery occlusion by manual aspiration thrombectomy. J Intervent Surg 2010; 2:110–114.Google ScholarPubMed
58.Imparato, AM. Vertebral artery reconstruction: a nineteen-year experience. J Vasc Surg 1986;2:626–634.CrossRefGoogle Scholar
59.Spetzler, RF, Hadley, MN, Martin, NA et al. Vertebrobasilar insufficiency: I. Microsurgical treatment of extracranial vertebrobasilar disease. J Neurosurg 1987;66:648–661.CrossRefGoogle ScholarPubMed
60.Kieffer, E, Koskas, F, Bahnini, A et al. Long-term results after reconstruction of the cervical vertebral artery. In Caplan, LR, Shifrin, EG, Nicolaides, AN, Moore, WS (eds.), Cerebrovascular ischaemia: investigation and management. Med-Orion, London, 1996, pp. 617–625.Google Scholar
61.Berguer, R., Flynn, L.M., Kline, R.A. Caplan, L.R. Surgical reconstruction of the extracranial vertebral artery: Management and outcome. J Vasc Surg 2000;31:9–18.CrossRefGoogle ScholarPubMed
62.Haghighi, Ab, Edgell, RC, Cruz-Flores, S, Zaidat, OO. Vertebral artery origin stenosis and its treatment. J Stroke Cerebrovasc Dis 2011;20:369–376.CrossRefGoogle Scholar
63.Stayman, An, Nogueira, RG, Gupta, R. A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis. Stroke 2011; 42:2212–2216.CrossRefGoogle ScholarPubMed
64.Dorros, G, Lewin, RF, Jamnadas, P, Mathiak, LM. Peripheral transluminal angioplasty of the subclavian and innominate arteries utilizing the brachial approach: acute outcome and follow-up. Cathet Cardiovasc Diagn 1990;19: 71–76.CrossRefGoogle ScholarPubMed
65.Hebrang, A, Maskovic, J, Tomac, B. Percutaneous transluminal angioplasty of the subclavian arteries: long-term results in 52 patients. AJR Am J Roentgenol 1991;156: 1091–1094.CrossRefGoogle ScholarPubMed
66.Millaire, A, Trinca, M, Marache, P et al. Subclavian angioplasty: immediate and late results in 50 patients. Cathet Cardiovasc Diagn 1993;29: 8–17.CrossRefGoogle ScholarPubMed
67.Motarjeme, A, Keifer, JW, Zuska, AJ, Nabawi, P. 1985. Percutaneous transluminal angioplasty for treatment of subclavian steal. Radiology 1985; 155: 611–613.CrossRefGoogle ScholarPubMed
68.Meyers, PM, Schumacher, HC, Tanji, K, Higashida, RT, Caplan, LR. Use of stents to treat intracranial cerebrovascular disease. Annu Rev Med 2007;58:107–122.CrossRefGoogle ScholarPubMed
69.Sundt, TM, Smith, HC, Campbell, JK et al. Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc 1980;55:673–680.Google ScholarPubMed
70.Piepgras, DG, Sundt, TM, Forbes, GS, Smith, HC. Balloon catheter transluminal angioplasty for vertebrobasilar ischemia. In Berguer, R, Bauer, R (eds.), Vertebrobasilar arterial occlusive disease. Raven Press, New York, 1984, pp. 215–224.Google Scholar
71.Gress, DR, Smith, WS, Dowd, CF et al. Angioplasty for intracranial symptomatic vertebrobasilar ischemia. Neurosurgery 2002;51:23–27.CrossRefGoogle ScholarPubMed
72.Gomez, CR, Misra, VK, Liu, MW et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 2000;31:95–99.CrossRefGoogle ScholarPubMed
73.Yu, W, Smith, WS, Singh, V et al. Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology 2005; 64:1055–1057.CrossRefGoogle ScholarPubMed
74.Kessler, IM, Mounayer, C, Piotin, M et al. The use of balloon-expandable stents in the treatment of intracranial arterial diseases: a 5 year single-center experience. AJNR Am J Neuroradiol 2005; 26: 2342–2348.Google ScholarPubMed
75.Henkes, H, Miloslavaski, E, Lowens, S et al. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 2005; 47: 222–228.CrossRefGoogle ScholarPubMed
76.Bose, A, Hartmann, M, Henkes, H et al. A novel, self-expanding nitinol stent in medically refractory intracranial atherosclerotic stenoses. The Wingspan Study. Stroke 2007;38:1531–1537.CrossRefGoogle ScholarPubMed
77.Groschel, K, Schnaudigel, S, Pilgram, SM, Wasser, K, Kastrup, A. A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009;40:e340–e347.CrossRefGoogle ScholarPubMed
78.Chimowitz, MI, Lynn, MJ, Derdeyn, CP et al. for the SAMMPRIS Investigators. Stenting versus Aggressive Medical Therapy for intracranial Arterial Stenosis. N Engl J Med 2011;365:993–1003.CrossRefGoogle ScholarPubMed
79.Fiorella, D, Derdeyn, CP, Lynn, MJ et al. for the SAMMPRIS Trial Investigators. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke 2012;43:2682–2688.CrossRefGoogle ScholarPubMed
80.Derdeyn, CP, Fiorella, D, Lynn, MJ et al. for the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS Trial. Neurosurgery 2013;72:777–795.CrossRefGoogle ScholarPubMed
81.Jiang, WJ, Srivastava, T, Gao, F, Du, B, Dong, KH, Xu, XT. Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 2006;66:1868–1872.CrossRefGoogle ScholarPubMed
82.Jiang, W-J, Du, B, Hon, SF et al. Do patients with basilar or vertebral artery stenosis have a higher stroke incidence poststenting. J Neurointervent Surg 2010;2:50–54.CrossRefGoogle ScholarPubMed
83.The EC-IC Bypass Study Group. Failure of the extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. N Engl J Med 1985;313:1191–1200.CrossRefGoogle Scholar
84.Bloom, AL, Thomas, DP. Haemostasis and thrombosis. Churchill-Livingstone, Edinburgh, 1987.Google Scholar
85.del Zoppo, GJ. Vascular hemostasis and brain embolism. In Caplan, LR, Manning, WJ (eds.), Brain embolism. Informa Healthcare, New York, 2006, pp. 243–258.Google Scholar
86.Francis, CW, Kaplan, KL. Principles of antithrombotic therapy. In Lichtman, MA, Kipps, TJ, Kaushansky, K, Beutler, E, Seligsohn, U, Prchal, JT (eds.), Williams hematology. McGraw-Hill, New York, 2006, pp. 283–300.Google Scholar
87.Hemker, HC, Lindhout, T. Interaction of platelet activation and coagulation. In Fuster, V, Topol, EJ, Nabel, EG (eds.), Atherothrombosiss and coronary artery disease, 2nd edition. Lippincott Williams & Wilkins, Philadelphia, 2005, pp. 569–581.Google Scholar
88.Ogata, J. Heart and vessel pathology in 142 stroke patients. Ann Neurol 2008;63:770–781.CrossRefGoogle ScholarPubMed
89.Marder, VJ, Chute, DJ, Starkman, S et al. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 2006; 37: 2086–2093.CrossRefGoogle ScholarPubMed
90.Liebeskind, DS, Sanossian, N, Young, WH et al. CT and MRI vessel signs reflect clot composition uin acute stroke. Stroke 2011;42:1237–1247.CrossRefGoogle Scholar
91.Di Nisio, M, Middledorp, S, Buller, H. Direct thrombin inhibitors. N Engl J Med 2005; 353:1028–1040.CrossRefGoogle ScholarPubMed
92.Bauer, KA. New anticoagulants: anti IIa vs anti Xa–is one better? J Thromb Thrombolysis 2006; 21:67–72.CrossRefGoogle ScholarPubMed
93.Connolly, SJ, Ezekowitz, MD, Yusuf, S et al. and the RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139–1151.CrossRefGoogle ScholarPubMed
94.Granger, CB, Alexander, JH, McMurray, JJV et al. for the ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981–992.CrossRefGoogle ScholarPubMed
95.Patel, MR, Mahaffey, KW, Garg, J et al. and the ROCKET AF Steering Committee for the ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883–891.CrossRefGoogle ScholarPubMed
96.Nurden, AT. Platelet function and pharmacology of antiplatelet drugs. Cerebrovasc Dis 1997; 7(Suppl 6): 2–9.CrossRefGoogle Scholar
97.Weksler, B. Antiplatelet agents in stroke prevention. Cerebrovasc Dis 2000; 10(Suppl 5): 41–48.CrossRefGoogle ScholarPubMed
98.Caplan, LR. Antiplatelet therapy in stroke: present and future. Cerebrovasc Dis 2006; 21 (Suppl 1): 1–6.CrossRefGoogle ScholarPubMed
99.Sacco, RL, Sivenius, J, Diener, H-C. Efficacy of aspirin plus extended- release dipyridamole in preventing recurrent stroke in high-risk populations. Arch Neurol 2005; 62:403–408.CrossRefGoogle ScholarPubMed
100.Kwon, SU, Cho, Y-J, Koo, J-S et al. Cilostazol prevents the progression of the symptomatic intracranial stenosis. The multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 2005; 36:782–786.CrossRefGoogle ScholarPubMed
101.Ameriso, S, lagos, R, Ferreira, LM et al. Cerebrovascular effects of cilostazol in patients with atherosclerotic disease. J Stroke Cerebrovasc Dis 2006; 15:273–276.CrossRefGoogle ScholarPubMed
102.Tcheng, JE. Differences among the parenteral glycoprotein IIb/IIIa inhibitors and implications for treatment. Am J Cardiol 1999; 83:7E–15E.CrossRefGoogle ScholarPubMed
103.Lefkovits, J, Plow, EF, Topol, EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995; 332:1553–15559.CrossRefGoogle ScholarPubMed
104.ESPS Group. European Stroke Prevention Study (ESPS): principal endpoints. Lancet 1987; 2:1351–1354.Google Scholar
105.Sivenius, J, Riekkinen, PJ, Smets, P, Laakso, M, Lowenthal, A. The European Stroke Prevention Study (ESPS): results by arterial distribution. Ann Neurol 1991;29:596–600.CrossRefGoogle ScholarPubMed
106.Chimowitz, MI, Kokkinos, J, Strong, J et al. for the Warfarin-Aspirin Symptomatic Intracranial Disease Study Group. Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995;45: 1488–1493.CrossRefGoogle ScholarPubMed
107.Chimowitz, MI, Lynn, MJ, Howlett-Smith, H et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352:1305–1316.CrossRefGoogle ScholarPubMed
108.Kasner, SE, Lynn, MJ, Chimowitz, MB et al. for the Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology 2006;67:1275–1278.CrossRefGoogle ScholarPubMed
109.Koroshetz, W. Warfarin, aspirin, and intracranial vascular disease. N Engl J Med 2005;352:1368–1370.CrossRefGoogle ScholarPubMed
110.Mohr, JP, Thompson, JLP, Lazar, RM et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001;345:1444–1451.CrossRefGoogle ScholarPubMed
111.Sacco, RL, Prabhakaran, S, Thompson, JL et al. for the WARSS investigators. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovasc Dis 2006; 22:4–12.CrossRefGoogle ScholarPubMed
112.Wong, KS, Chen, C, Ng, PW et al. for the FISS-tris Study Investigators. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurol 2007;6:407–413.CrossRefGoogle ScholarPubMed
113.Wong, QS, Chen, C, Chen, XY et al. Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease. Subgroup analyses from the Fraxiparin in Stroke Study for the treatment of Ischemic Stroke (FISS-tris) Study. Stroke 2012:43:346–349.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Treatment
  • Louis R. Caplan
  • Book: Vertebrobasilar Ischemia and Hemorrhage
  • Online publication: 05 May 2015
  • Chapter DOI: https://doi.org/10.1017/CBO9781139019453.007
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Treatment
  • Louis R. Caplan
  • Book: Vertebrobasilar Ischemia and Hemorrhage
  • Online publication: 05 May 2015
  • Chapter DOI: https://doi.org/10.1017/CBO9781139019453.007
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Treatment
  • Louis R. Caplan
  • Book: Vertebrobasilar Ischemia and Hemorrhage
  • Online publication: 05 May 2015
  • Chapter DOI: https://doi.org/10.1017/CBO9781139019453.007
Available formats
×